# NRX PHARMACEUTICALS INC \*W EXP 05/24/202

NRX PHARMACEUTICALS INC *W EXP 05/24/202 is a security (CUSIP 629444118) tracked across SEC portfolio filings. 3 institutional managers reported $347 on Form 13F as of 2026-03-31.

## Summary

- Issuer: NRX PHARMACEUTICALS INC
- Class: \*W EXP 05/24/202
- CUSIP: 629444118
- 13F holders: 3
- 13F value: $347
- 13F period: 2026-03-31
- N-PORT fund positions: 0

## Top institutional holders (Form 13F)

| Manager | Location | Value | Shares |
| --- | --- | --- | --- |
| [WOLVERINE ASSET MANAGEMENT LLC](https://search.stillhousedata.com/firm/138907) | CHICAGO, IL | $347 | 23,593 |
| UBS Group AG | Zurich, V8 | — | 13 |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | BIRMINGHAM, AL | — | 0 |

## More

- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/security/629444118.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.